These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2230749)

  • 21. Substance use and cognition in early psychosis.
    Pencer A; Addington J
    J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive deficit in schizophrenia: comparative analysis of positive and negative subtype and predictors of positive subtype.
    Cvetić T; Vuković O
    Psychiatr Danub; 2006 Jun; 18(1-2):4-11. PubMed ID: 16804494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of effort, cognitive expectancy appraisals and coping style in the maintenance of the negative symptoms of schizophrenia.
    Avery R; Startup M; Calabria K
    Psychiatry Res; 2009 May; 167(1-2):36-46. PubMed ID: 19339056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unrecognized cocaine use among schizophrenic patients.
    Shaner A; Khalsa ME; Roberts L; Wilkins J; Anglin D; Hsieh SC
    Am J Psychiatry; 1993 May; 150(5):758-62. PubMed ID: 8480822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual information processing in positive, mixed, and negative schizophrenic syndromes.
    Weiner RU; Opler LA; Kay SR; Merriam AE; Papouchis N
    J Nerv Ment Dis; 1990 Oct; 178(10):616-26. PubMed ID: 2230746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nosologic specificity of psychopathologic findings in schizophrenic and depressed patients].
    Schneider F; Böser H; Heimann H; Fus I; Friedrich J
    Wien Klin Wochenschr; 1992; 104(3):51-5. PubMed ID: 1570706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrinsic motivation in schizophrenia: relationships to cognitive function, depression, anxiety, and personality.
    Barch DM; Yodkovik N; Sypher-Locke H; Hanewinkel M
    J Abnorm Psychol; 2008 Nov; 117(4):776-787. PubMed ID: 19025225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Family history in patients with schizophrenia and depressive symptoms.
    Babinkostova Z; Stefanovski B
    Prilozi; 2011; 32(1):219-28. PubMed ID: 21822190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profile of cognitive deficits and associations with depressive symptoms and intelligence in chronic early-onset schizophrenia patients.
    Jepsen JR; Fagerlund B; Pagsberg AK; Christensen AM; Nordentoft M; Mortensen EL
    Scand J Psychol; 2013 Oct; 54(5):363-70. PubMed ID: 23786210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
    Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
    Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and cognitive factors associated with verbal memory task performance in patients with schizophrenia.
    Brébion G; Gorman JM; Malaspina D; Sharif Z; Amador X
    Am J Psychiatry; 2001 May; 158(5):758-64. PubMed ID: 11329399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in cognitive function of patients with chronic schizophrenia.
    Han M; Huang XF; Chen DC; Xiu MH; Hui L; Liu H; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):358-63. PubMed ID: 22820676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thought disorder severity in compromised, deteriorated, and preserved intellectual course of schizophrenia.
    Mercado CL; Johannesen JK; Bell MD
    J Nerv Ment Dis; 2011 Feb; 199(2):111-6. PubMed ID: 21278540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive functions and psychopathological symptoms in early-onset schizophrenia.
    Banaschewski T; Schulz E; Martin M; Remschmidt H
    Eur Child Adolesc Psychiatry; 2000 Mar; 9(1):11-20. PubMed ID: 10795851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale.
    Mass R; Schoemig T; Hitschfeld K; Wall E; Haasen C
    Schizophr Bull; 2000; 26(1):167-77. PubMed ID: 10755679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis.
    Béchard-Evans L; Iyer S; Lepage M; Joober R; Malla A
    Psychol Med; 2010 May; 40(5):749-59. PubMed ID: 19732482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.
    Wobrock T; Sittinger H; Behrendt B; D'Amelio R; Falkai P; Caspari D
    Eur Arch Psychiatry Clin Neurosci; 2007 Jun; 257(4):203-10. PubMed ID: 17131214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.